Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. 20-F Report Annual and Transition Report of Foreign Private Issuers
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 15-15D Other 15-15D
  4. S-8 POS Other Post-effective Amendment
  5. 6-K Event Report of Foreign Issuer
  6. EFFECT Other Notice of Effectiveness
  7. 6-K Event Report of Foreign Issuer
  8. SC 13D/A Stake Beneficial Ownership Report
  9. POS AM Other Post-effective Amendment for Registration Statement
  10. 6-K Event Report of Foreign Issuer
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. 6-K Event Report of Foreign Issuer
  17. 6-K Event Report of Foreign Issuer
  18. SC 13D Stake Beneficial Ownership Report
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 6-K Event Report of Foreign Issuer

Page 18 of 19 · 368 filings